Tag: NEO:CYBN

February 22, 2021

Follow the Money: Investments in Mental Health

The mental health wellness sector is poised to expand as mental health issues continue to disrupt the world.
February 10, 2021

Psychedelics Sentiment Strong, Investors Ready for New Year

INN spoke to a pair of psychedelics companies about industry engagement and conversations they're having with interested investors.
February 9, 2021

The Future of Mental Health and Addiction Therapy: Why Capital is Flowing into Psychedelics

The capital markets have seen a snowballing effect as innovations in mental health therapy materialize through psychedelic research and medicine.
January 26, 2021

First Psychedelics ETF Officially Launches in Canadian Market

Horizons ETFs will begin offering investors exposure to the rising psychedelics market with the launch of a brand-new fund.
December 23, 2020

Psychedelics Outlook 2021: How Far Can This Industry Go?

After a year in the spotlight, what’s the future potential of the psychedelics industry?
December 16, 2020

Psychedelics Trends 2020: The Heat is On

2020 marked the beginning of the psychedelics investment story as the capital markets fully embraced the alternative drug sector.
December 7, 2020

CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics as Part of its Commitment to Strategic Growth

Cybin to host conference call today, December 7, 2020, at 5:00 p.m. ET